Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.

Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia. Leuk Lymphoma. 2018 11; 59(11):2686-2691.

View in: PubMed